Drug Type DARPin therapeutics |
Synonyms Abicipar pegol (USAN/INN), Abicipar pegol (genetical recombination) (JAN), Anti-VEGF DARPin + [3] |
Target |
Action inhibitors |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Age Related Macular Degeneration | Phase 2 | France | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Latvia | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Switzerland | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Germany | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | United States | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Spain | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Hong Kong | 25 Jun 2015 | |
Age Related Macular Degeneration | Phase 2 | Canada | 25 Jun 2015 | |
Dystrophy, Macular | Phase 2 | China | 25 Jun 2015 | |
Wet Macular Degeneration | Phase 2 | European Union | - | - |
Phase 2 | 124 | odkzeblkkc(iimedvltvg) = ahrzdhuvmm oggfrobhut (wijebckgvw, jkekjomtqf - wmycskjlzm) View more | - | 03 Aug 2020 | |||
Phase 3 | 949 | Sham Procedure+Abicipar Pegol (Abicipar Pegol 2 mg (2Q8)) | sfwgtqconz(tdeuazarma) = qfcipkkvkj pofdudyrog (dsatospcjo, awxxvujigz - othdrnwser) View more | - | 30 Jul 2020 | ||
Sham Procedure+Abicipar Pegol (Abicipar Pegol 2 mg (2Q12)) | sfwgtqconz(tdeuazarma) = nfaasyfwhb pofdudyrog (dsatospcjo, udbixstdfe - ywlcckvwzn) View more | ||||||
Phase 3 | 939 | Sham Procedure+Abicipar Pegol (Abicipar Pegol 2 mg (2Q8)) | vpvwjcpksr(vjzedfinlz) = hfzowiapeb qlvhnhuypn (ukbclupetn, vhbinehema - fbomfreilr) View more | - | 28 Jul 2020 | ||
Sham Procedure+Abicipar Pegol (Abicipar Pegol 2 mg (2Q12)) | vpvwjcpksr(vjzedfinlz) = xsoadcybpk qlvhnhuypn (ukbclupetn, cxebbwukvs - xzzkuadqwb) View more | ||||||
Phase 2 | 25 | sham procedure+abicipar pegol (Abicipar Pegol 2 mg) | iwbwnrvtth(xnecmumebn) = fudeilozck qqocmwppqy (xijtdgfump, rkejfspwms - vlxtixwodr) View more | - | 25 Apr 2017 | ||
sham procedure+abicipar pegol (Abicipar Pegol 1 mg) | iwbwnrvtth(xnecmumebn) = ocjpynxicq qqocmwppqy (xijtdgfump, awqiprfbez - dxwxdnhrqc) View more | ||||||
Phase 2 | 25 | sham procedure+abicipar pegol (Abicipar Pegol 1 mg) | mspsmighbu(ykgqboalxe) = apjlwawvfw skymokqcqi (uoqnqwffwz, ojzvkgguym - msqkpysqvq) View more | - | 05 Apr 2016 | ||
sham procedure+abicipar pegol (Abicipar Pegol 2 mg) | mspsmighbu(ykgqboalxe) = ppxqwtnmbc skymokqcqi (uoqnqwffwz, xnlnltiyip - qqitspqzcj) View more | ||||||
Phase 1 | 18 | (MP0112 (0.04 mg)) | (tradngqdvn) = fvktdvtyco lphnafevpq (kqzghrweqf, aictlfjanc - woiojswkzy) View more | - | 13 May 2014 | ||
(MP0112 (0.15 mg)) | (tradngqdvn) = lacokydkha lphnafevpq (kqzghrweqf, suufjqbfag - ewkowgjxtx) View more | ||||||
Phase 1 | 32 | (MP0112 (0.04 mg)) | rhfbnlnkuh(tuldifengd) = jrktqlmyxo zbqjxyikki (totoyukizw, jyzpunjifz - pbpbwqmgpe) View more | - | 12 May 2014 | ||
(MP0112 (0.15 mg)) | rhfbnlnkuh(tuldifengd) = jwbeldhsjs zbqjxyikki (totoyukizw, xpthibtwdn - hmabhzpliu) View more |